BOLTON SECURITIES CORPORATION’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2K Buy
+405
New +$10.4K ﹤0.01% 1589
2025
Q3
$2.21K Buy
+146
New +$1.81K ﹤0.01% 1814

Other funds holding ROIV

BOLTON SECURITIES CORPORATION's ROIV Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Roivant Sciences (ROIV) in Q1 2026: 405 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #1589 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in ROIV as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in ROIV in Q3 2025 and has held it in 2 quarters since. 449 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 405 shares of Roivant Sciences worth $11.2K as of Q1 2026.
  • Roivant Sciences was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1589 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Roivant Sciences in Q3 2025 and has held it in 2 quarters since.
  • 449 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.